Aethlon Medical, based in San Diego with 14 employees, develops diagnostic and therapeutic products, including the FDA-designated Hemopurifier for treating advanced cancer and life-threatening viruses.
AEMD has been in the news recently: Aethlon Medical (AEMD) is scheduled to release its quarterly earnings report on June 26, 2025. The company Gainers has reported a 15% increase in profits this quarter, reflecting strong sales growth and improved market performance.
📡️ Health Care
In The News
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
